Peptide user suffers torn oesophagus after using unapproved drug | ABC NEWS
Community Score: 50% | 21.4K views | 4w
0 community ratings: null thumbs up, null thumbs down
The Therapeutic Goods Administration (TGA) has revealed a person suffered a torn oesophagus after using an unapproved weight-loss peptide labelled as retatrutide. Laboratory testing found the product contained no retatrutide, but instead a high dose of undeclared weight-loss drug semaglutide. Retatrutide is currently undergoing clinical trials in humans and has not been approved by the Therapeutic Goods Administration. Subscribe: http://ab.co/1svxLVE Read more here: https://www.abc.net.au/news/2026-09-14/tga-peptide-warning-retatrutide-torn-oesophagus/107143510 Note: In most cases, our captions are auto-generated. #ABCNEWS #ABCNEWSAustralia
Tags: Australia, abc, abc news, news, peptide, GLP-1, semaglutide, retatrutide, ozempic, wegovy, internet peptides, unapproved peptides, illegal peptides, TGA, peptide side effects, ozempic side effects, wegovy side effects, GLP 1 side effects, peptide weight loss, weight loss drug
More from ABC News (Australia)
- The biggest market sell-off since 'Liberation Day' | The Business | ABC NEWS — Score: 50%
- Designer Katie Perry wins trademark case against pop star | ABC NEWS — Score: 50%
- A look around the NT as residents deal with flooding emergency | ABC NEWS — Score: 50%
- Bundaberg homes inundated after Burnett River peaks | ABC News — Score: 50%
- Reindeer races in Finland draw international crowds | The World | ABC NEWS — Score: 50%
- Grave fears for Iranian footballers after Australia asylum saga | The World | ABC News — Score: 50%